RT Journal Article
SR Electronic
T1 Managing IBD in patients with previous cancers
JF Frontline Gastroenterology
JO Frontline Gastroenterol
FD BMJ Publishing Group Ltd
SP e44
OP e50
DO 10.1136/flgastro-2022-102187
VO 13
IS e1
A1 Minnis-Lyons, Sarah E
A1 Aiken, Zara
A1 Chow, Shien
A1 Din, Shahida
YR 2022
UL http://fg.bmj.com/content/13/e1/e44.abstract
AB A frequent dilemma faced in the inflammatory bowel disease (IBD) clinic is how to best treat a patient with a previous cancer diagnosis. The changing demographics of our patient population will make this quandary more common. Previous guidance has emphasised the importance of lengthy postcancer drug holidays and cautious use of IBD therapies. However, accumulating evidence suggests this approach may be unnecessarily conservative. This review considers recent evidence on the safety of IBD drugs, cancer and recurrent cancer risk in patients with IBD and provides a framework for shared decision making involving patient, gastroenterologist and oncologist.